In vitro antagonism of benzodiazepine binding to cerebral receptors by H1 and H2 antihistamines.
Antihistamines directed at either the H1 or H2 histamine receptor have the well-known side effect of sedation. The mechanism for the CNS depressant action of antihistamines is unknown. We examine here the possibility that the mechanism may involve modulation of the cerebral benzodiazepine receptor. We demonstrate that cimetidine and pyrilamine are competitive antagonists of 3H-benzodiazepine binding to human cerebral receptor in vitro. The inhibition of radioligand binding was not specific for benzodiazepine receptor, however, since antihistamines also antagonized binding to GABA, opiate, and muscarinic acetylcholine receptor. The interaction of antihistamine with CNS receptors other than histamine receptor may explain, at least in part, the side effect of sedation.
D001667:Binding, Competitive; D001921:Brain / Q000187:drug effects*; D002927:Cimetidine / Q000378:metabolism; D003975:Diazepam / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006635:Histamine H2 Antagonists / Q000494:pharmacology*; D006801:Humans; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D011956:Receptors, Cell Surface / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D011963:Receptors, GABA-A; D011976:Receptors, Muscarinic / Q000187:drug effects; D011957:Receptors, Opioid / Q000187:drug effects; D013329:Structure-Activity Relationship
D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D011943:Receptors, Adrenergic, beta; D011956:Receptors, Cell Surface; D011955:Receptors, Drug; D011963:Receptors, GABA-A; D011976:Receptors, Muscarinic; D011957:Receptors, Opioid; D002927:Cimetidine; D003975:Diazepam